Literature DB >> 1324791

Effect on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18.

C Steele1, P G Sacks, K Adler-Storthz, E J Shillitoe.   

Abstract

Some human squamous cell carcinomas contain DNA of human papillomaviruses (HPV) and express RNA from the E6 and E7 genes. We have examined the effect of plasmids that express antisense RNA of these genes on the growth of the human cancer cell lines HeLa, C4-1, and 1483, which contain HPV type 18 DNA. As controls, the human cancer cell line 183 and the Vero line of monkey kidney cells were used, which do not contain HPV. Plasmids were introduced into the cells by electroporation; cells that contained HPV type 18 accepted the antisense-expressing plasmids at a lower frequency than the cells that lacked HPV. Cell lines were developed from HeLa cells that contained sense- or antisense-expressing plasmids, and lines that contained antisense-expressing plasmids showed slower growth, reduced ability to form colonies in soft agar, and increased serum requirements. The use of antisense HPV RNA might be a suitable approach to gene therapy of HPV-expressing human cancers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324791

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.

Authors:  Angela M Bodles-Brakhop; Richard Heller; Ruxandra Draghia-Akli
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

2.  Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.

Authors:  K Butz; C Denk; A Ullmann; M Scheffner; F Hoppe-Seyler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Effects of human papillomavirus type-specific antisense oligonucleotides on cervical cancer cells containing papillomavirus type 16.

Authors:  Y F Wong; T K Chung; T H Cheung; S K Lam; A M Chang
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

5.  Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase.

Authors:  T Laitala; H K Väänänen
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 6.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

7.  Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.

Authors:  M von Knebel Doeberitz; C Rittmüller; F Aengeneyndt; P Jansen-Dürr; D Spitkovsky
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

Review 8.  Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites.

Authors:  Vjekoslav Tomaić
Journal:  Cancers (Basel)       Date:  2016-10-19       Impact factor: 6.639

9.  Correlation between tumorigenicity and expression levels or splicing patterns of transcripts of the human papillomavirus type 16 E6 gene.

Authors:  T Inoue; S Kyo; T Kiyono; M Ishibashi; H Ishiwatari; Y I Hwang; M Yutsudo; A Hakura
Journal:  Jpn J Cancer Res       Date:  1994-04

10.  Growth dependence of human papillomavirus 16 DNA-positive cervical cancer cell lines and human papillomavirus 16-transformed human and rat cells on the viral oncoproteins.

Authors:  S Watanabe; T Kanda; K Yoshiike
Journal:  Jpn J Cancer Res       Date:  1993-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.